Recent Advances in the Synthesis of Acyclic Nucleosides and Their Therapeutic Applications

Overview

Journal Top Curr Chem (Cham)

Publisher Springer

Specialty Chemistry

Date 2024 Oct 23

PMID 39441318

Authors

Sumit Kumar

Aditi Arora

Riya Chaudhary

Rajesh Kumar

Christophe Len

Monalisa Mukherjee

Brajendra K Singh

Virinder S Parmar

Affiliations

Soon will be listed here.

Abstract

DNA is commonly known as the "molecule of life" because it holds the genetic instructions for all living organisms on Earth. The utilization of modified nucleosides holds the potential to transform the management of a wide range of human illnesses. Modified nucleosides and their role directly led to the 2023 Nobel prize. Acyclic nucleosides, due to their distinctive physiochemical and biological characteristics, rank among the most adaptable modified nucleosides in the field of medicinal chemistry. Acyclic nucleosides are more resistant to chemical and biological deterioration, and their adaptable acyclic structure makes it possible for them to interact with various enzymes. A phosphonate group, which is linked via an aliphatic functionality to a purine or a pyrimidine base, distinguishes acyclic nucleoside phosphonates (ANPs) from other nucleotide analogs. Acyclic nucleosides and their derivatives have demonstrated various biological activities such as anti-viral, anti-bacterial, anti-cancer, anti-microbial, etc. Ganciclovir, Famciclovir, and Penciclovir are the acyclic nucleoside-based drugs approved by FDA for the treatment of various diseases. Thus, acyclic nucleosides are extremely useful for generating a variety of unique bioactive chemicals. Their biological activities as well as selectivity is significantly influenced by the stereochemistry of the acyclic nucleosides because chiral acyclic nucleosides have drawn a lot of interest due to their intriguing biological functions and potential as medicines. For example, tenofovir's (R) enantiomer is roughly 50 times more potent against HIV than its (S) counterpart. We can confidently state, "The most promising developments are yet to come in the realm of acyclic nucleosides!" Herein, we have covered the most current developments in the field of chemical synthesis and therapeutic applications of acyclic nucleosides based upon our continued interest and activity in this field since mid-1990's.

References

Bernard M, Bazin E, Petiot N, Lemdani K, Commandeur S, Verdelet C . The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system. Mol Ther Nucleic Acids. 2023; 32:794-806. PMC: 10280092. DOI: 10.1016/j.omtn.2023.05.004. View

Kariko K, Buckstein M, Ni H, Weissman D . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005; 23(2):165-75. DOI: 10.1016/j.immuni.2005.06.008. View

De Clercq E . Dancing with chemical formulae of antivirals: a personal account. Biochem Pharmacol. 2013; 86(6):711-25. DOI: 10.1016/j.bcp.2013.07.012. View

Simonis A, Theobald S, Fatkenheuer G, Rybniker J, Malin J . A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2. EMBO Mol Med. 2020; 13(1):e13105. PMC: 7646058. DOI: 10.15252/emmm.202013105. View

Guinan M, Benckendorff C, Smith M, Miller G . Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues. Molecules. 2020; 25(9). PMC: 7248840. DOI: 10.3390/molecules25092050. View

Burke M, Borland K, Litosh V . Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future. Curr Top Med Chem. 2015; 16(11):1231-41. DOI: 10.2174/1568026615666150915111933. View

El Kouni M . Trends in the design of nucleoside analogues as anti-HIV drugs. Curr Pharm Des. 2002; 8(8):581-93. DOI: 10.2174/1381612024607171. View

Winn M, Goss R, Kimura K, Bugg T . Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis. Nat Prod Rep. 2010; 27(2):279-304. DOI: 10.1039/b816215h. View

Chien M, Anderson T, Jockusch S, Tao C, Li X, Kumar S . Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19. J Proteome Res. 2020; 19(11):4690-4697. PMC: 7640960. DOI: 10.1021/acs.jproteome.0c00392. View

10.

Chandra G, Patel S, Panchal M, Singh D . -adenosyl-L-homocysteine Hydrolase: Its Inhibitory Activity Against and Development of Malaria Drugs. Mini Rev Med Chem. 2020; 21(7):833-846. DOI: 10.2174/1389557521666201218155321. View

11.

Robins M, Hatfield P, Balzarini J, De Clercq E . Nucleic acid related compounds. 47. Synthesis and biological activities of pyrimidine and purine "acyclic" nucleoside analogues. J Med Chem. 1984; 27(11):1486-92. DOI: 10.1021/jm00377a018. View

12.

Baszczynski O, Janeba Z . Medicinal chemistry of fluorinated cyclic and acyclic nucleoside phosphonates. Med Res Rev. 2013; 33(6):1304-44. DOI: 10.1002/med.21296. View

13.

Keough D, Hockova D, Holy A, Naesens L, Skinner-Adams T, de Jersey J . Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics. J Med Chem. 2009; 52(14):4391-9. DOI: 10.1021/jm900267n. View

14.

Topalis D, Pradere U, Roy V, Caillat C, Azzouzi A, Broggi J . Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. J Med Chem. 2010; 54(1):222-32. DOI: 10.1021/jm1011462. View

15.

Spacek P, Keough D, Chavchich M, Dracinsky M, Janeba Z, Naesens L . Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase. J Med Chem. 2017; 60(17):7539-7554. DOI: 10.1021/acs.jmedchem.7b00926. View

16.

ELION G, Furman P, Fyfe J, de Miranda P, Beauchamp L, Schaeffer H . Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977; 74(12):5716-20. PMC: 431864. DOI: 10.1073/pnas.74.12.5716. View

17.

Kumar R, Sharma N, Nath M, Saffran H, Tyrrell D . Synthesis and antiviral activity of novel acyclic nucleoside analogues of 5-(1-azido-2-haloethyl)uracils. J Med Chem. 2001; 44(24):4225-9. DOI: 10.1021/jm010227k. View

18.

Eger K, Klunder E, Schmidt M . Synthesis of new acyclic pyrimidine nucleoside analogs as potential antiviral drugs. J Med Chem. 1994; 37(19):3057-61. DOI: 10.1021/jm00045a010. View

19.

DAlonzo D, Guaragna A, Palumbo G . Exploring the role of chirality in nucleic acid recognition. Chem Biodivers. 2011; 8(3):373-413. DOI: 10.1002/cbdv.201000303. View

20.

Hockova D, Keough D, Janeba Z, Wang T, de Jersey J, Guddat L . Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases. J Med Chem. 2012; 55(13):6209-23. DOI: 10.1021/jm300662d. View